glp-1 and nerve pain Evidence that physiological metabolic actions of are dependent on The protective role of GLP-1

By mimicking the action of the GLP-1 hormone, semaglutide helps to reduce appetite and increase feelings of fullness and satiety after meals

Any patient with concerning cardiovascular symptoms should undergo thorough assessment, and the decision to continue Wegovy should be individualised based on the balance of benefits and risks in each clinical scenario

References Aronne, L

Can we marry these two together

Key takeaways Animal studies show BPC-157 improves gastric motility and protects against gastric damage in rats No human clinical trial has tested BPC-157 for gastroparesis specifically BPC-157 modulates the nitric oxide system and may interact with vagal nerve function, both relevant to gastroparesis Oral administration (250-500 mcg daily) is preferred over injection for GI-targeted effects BPC-157 is unusually stable in stomach acid, making oral delivery viable Patients should work with their gastroenterologist before adding BPC-157 to their gastroparesis management What is gastroparesis and why is it hard to treat

Telogen effluvium hair loss usually starts about 3 months after weight loss begins, lasts for several months, and reverses over 6 to 12 months once your weight loss is stabilized, although the timeline can vary